A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Clinical trial NCT06221969 · COMPLETED
Trial details
- NCT number
- NCT06221969
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-16
- Primary completion
- 2026-03-04
- Enrollment
- 1024
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.